Latest News and Press Releases

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apellis Pharmaceuticals, Inc. (“Apellis” or the “Company”) (NASDAQ: APLS). Such investors...

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hayward Holdings, Inc. (“Hayward” or the “Company”) (NYSE: HAYW).   Such investors are...

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE).   Such...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN).   Such investors are advised to...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. (“Syneos” or the “Company”) (NASDAQ: SYNH). Such investors are advised...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Eos Energy Enterprises, Inc. (“Eos” or the “Company”) (NASDAQ: EOSE). Such investors are...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Party City Holdco (“Party City” or the “Company”) (OTCMKTS: PRTYQ). Such investors are...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FMC Corporation (“FMC” or the “Company”) (NYSE: FMC).   Such investors are advised to...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cryoport, Inc. (“Cryoport” or the “Company”) (NASDAQ: CYRX).  Such investors are advised...

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. (“Byrna” or the “Company”) (NASDAQ: BYRN). Such investors are...